New funding to support platform advancements and proprietary pipeline expansion NEW YORK – Schrödinger today announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry-leading computational platform and expansion of its therapeutic pipeline. New investors include […]
– Avantor enterprise value grows from $280 million in 2010 to over $14 billion today, under New Mountain’s ownership – Avantor has emerged as a global leader in life sciences materials NEW YORK–New Mountain Capital, LLC, (“New Mountain”), a growth-oriented private equity firm with over $20 billion in assets under management, today announced the initial […]
Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S. PARIS – DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe’s largest and most experienced healthcare investment firms. Bpifrance, through its Large Venture fund, joined the round, alongside existing investors Illumina Ventures, […]
BRANFORD, Conn. — IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in oncology & beyond, today announced that it had raised $25 million in Series C funding. The round was led by Northpond Ventures and included new strategic investment along with current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and Connecticut Innovations. In […]
Unchained Labs gets teed up for the future, snags $50 million debt facility with Silicon Valley Bank
PLEASANTON, Calif. — Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, today announced it has closed a $50 million debt facility from Silicon Valley Bank (SVB) to further support its working capital growth, along with adding dry powder for future acquisitions. The agreement allows the company to retire its […]
On May 9, 2019, MGI disclosed that its first round of fundraising exceeded US$200 million, the largest amount of capital raised in the genetic field in China in 2018. Investors included well-known institutions such as CITIC, Jinshi Capital, Songhe Capital and Dongzheng Capital. MGI Highlights Rapid Progress in Transforming Industry In recent years, the gene […]
Genome Diagnostics B.V. (“GenDx”) announced today that Ampersand Capital Partners has completed a minority, growth equity investment in the company. Wietse Mulder, PhD., remains the majority shareholder and CEO of GenDx. The partnership between Ampersand and GenDx aims to foster sustainable growth, both organically and through M&A activities in the molecular diagnostic products and services […]
FUNDS WILL ENABLE DEVELOPMENT OF INSTRUMENT TO RAPIDLY AND DIRECTLY ANALYZE DRINKING WATER SAMPLES AT THE POINT OF COLLECTION. FAYETTEVILLE, AR – Zebra Analytix™, a VIC Technology Venture Development portfolio company, announced today that it has received a National Institute of Environment Health Sciences (NIEHS) Small Business Innovation Research (SBIR) grant in the amount of $225,000. […]
Cambridge, United Kingdom – Congenica, the global clinical decision support platform provider, today announced it has raised a further £13.25 ($17.1) million in additional equity investment, led by Parkwalk Advisors. The round attracted new strategic investors, including Digital China Health Technologies Corporation Limited (DCHealth), alongside follow-on funding from existing investors. The total amount raised across its B […]
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced it has closed $17.5 million in a growth equity funding round. This Series E funding brings the company’s total to $70M, making 908 Devices the most well-resourced upstart in the multibillion-dollar mass spectrometry market. The round was led by Northpond Ventures, […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
